Delivery Order SPE2DB22D2007-SPE2DB24FJ0PW
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,196.38 firm fixed-price delivery order is for the supply of 4,558,479,293 units of Famotidine 20 mg tablets. The contract has an ultimate completion date of September 16, 2022 and was awarded on September 15, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $25,807.41 firm fixed-price contract is for the delivery of 4,565,286 units of Famotidine 40 mg tablets. The contract has a period of performance through July 30, 2024 and does not utilize a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Famotidine 40 mg tablets, a generic medication used to treat gastrointestinal conditions. The contract has a ceiling value of $12,383.71 and a period of performance through April 21, 2023. This delivery order is part of a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.23 Firm Fixed Price Delivery Order is for the supply of Famotidine 40 mg/5 ml suspension in 50 ml containers. The contract has a period of performance through March 22, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,499.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566618142 - Famotidine 40 mg/5 ml Suspension, 50 ml, with an ultimate completion date of December 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Famotidine 40 mg/5 ml suspension, a pharmaceutical product, to support military healthcare programs. The firm fixed-price contract has a ceiling value of $1,879.04 and an ultimate completion date of May 2, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under a larger Indefinite Delivery Contract...
- This is a delivery order contract with a firm fixed price awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 500 tablets of 40 mg famotidine, a medication used to treat acid reflux and peptic ulcers. The contract has a ceiling value of $52,439.24 and an ultimate completion date of April 19, 2023. This delivery order is part of a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Famotidine 40 mg/5 ml suspension in 50 ml quantities, with a ceiling value of $1,392.09. The contract was awarded on August 14, 2025, on a firm fixed price basis with an ultimate completion date of August 15, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,893.37 to AmerisourceBergen Drug Corp for the supply of Famotidine 20 mg Piggyback 50ml, a gastrointestinal medication commonly used in medical settings. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, under a firm fixed-price delivery order contract with no set-aside designation. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This specific delivery order is for...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0PWDelivery Order
This federal contract award, with an ID of SPE2DB22D2007/SPE2DB24FJ0PW, is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of 4,563,971,240 tablets of the pharmaceutical Famotidine 20 mg, with a firm fixed price of $1,147.18 and a period of performance through March 15, 2024. The award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/14/24 |